Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,946 | 122 | 99.3% |
| Education | $13.89 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $357.15 | 29 | $0 (2019) |
| Novo Nordisk Inc | $324.19 | 21 | $0 (2024) |
| Lucid Diagnostics Inc. | $305.85 | 14 | $0 (2024) |
| Amgen Inc. | $192.12 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $175.11 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $106.79 | 7 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $81.45 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $80.22 | 5 | $0 (2018) |
| Exact Sciences Corporation | $43.04 | 2 | $0 (2024) |
| Purdue Pharma L.P. | $38.94 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $236.00 | 12 | Lucid Diagnostics Inc. ($123.95) |
| 2023 | $226.15 | 10 | Lucid Diagnostics Inc. ($181.90) |
| 2022 | $62.25 | 4 | Novo Nordisk Inc ($30.93) |
| 2021 | $77.74 | 5 | AstraZeneca Pharmaceuticals LP ($31.91) |
| 2020 | $211.49 | 13 | Novo Nordisk Inc ($133.06) |
| 2019 | $244.28 | 16 | Sunovion Pharmaceuticals Inc. ($93.19) |
| 2018 | $383.48 | 30 | Sunovion Pharmaceuticals Inc. ($152.84) |
| 2017 | $518.45 | 33 | Sunovion Pharmaceuticals Inc. ($111.12) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $18.15 | General |
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.26 | General |
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $21.06 | General |
| 03/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology | ||||||
| 02/23/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.61 | General |
| 02/05/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 01/26/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $17.79 | General |
| 12/15/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $21.63 | General |
| 11/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardio-renal | ||||||
| 10/20/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 09/13/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $23.91 | General |
| 08/23/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $19.89 | General |
| 06/15/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $32.90 | General |
| 04/27/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $20.08 | General |
| 02/17/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $20.42 | General |
| 02/03/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $25.20 | General |
| 01/18/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Oncology | ||||||
| 12/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diabetes | ||||||
| 06/13/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 171 | 324 | $87,348 | $25,656 |
| 2022 | 4 | 303 | 552 | $128,889 | $46,272 |
| 2021 | 3 | 267 | 495 | $102,204 | $37,197 |
| 2020 | 4 | 425 | 1,056 | $228,950 | $63,106 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 294 | $77,028 | $22,456 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $10,320 | $3,201 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 195 | 442 | $99,292 | $36,508 | 36.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $21,996 | $6,467 | 29.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 11 | 11 | $2,332 | $1,673 | 71.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 33 | $5,269 | $1,623 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 345 | $73,980 | $28,781 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 116 | $16,936 | $4,666 | 27.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $11,288 | $3,750 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 251 | 692 | $146,972 | $41,677 | 28.4% |
| 80307 | Testing for presence of drug | Office | 2020 | 67 | 239 | $59,750 | $14,693 | 24.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 83 | 101 | $14,261 | $4,151 | 29.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 24 | 24 | $7,968 | $2,586 | 32.5% |
About Dr. Michael Reiner, M.D
Dr. Michael Reiner, M.D is a Internal Medicine healthcare provider based in Pahrump, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285698381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Reiner, M.D has received a total of $1,960 in payments from pharmaceutical and medical device companies, with $236.00 received in 2024. These payments were reported across 123 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,946).
As a Medicare-enrolled provider, Reiner has provided services to 1,166 Medicare beneficiaries, totaling 2,427 services with total Medicare billing of $172,231. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Neuromusculoskeletal Medicine & OMM, Geriatric Medicine
- Location Pahrump, NV
- Active Since 04/14/2006
- Last Updated 07/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285698381
Products in Payments
- Ozempic (Drug) $177.93
- LONHALA MAGNAIR (Drug) $163.41
- FARXIGA (Drug) $120.15
- ENTRESTO (Drug) $106.79
- Victoza (Drug) $103.04
- Prolia (Biological) $94.53
- Utibron (Drug) $82.62
- XIFAXAN (Drug) $81.45
- Otezla (Drug) $62.76
- BROVANA (Drug) $61.74
- STIOLTO (Drug) $55.14
- UTIBRON (Drug) $49.38
- Cologuard Collection Kit (Device) $43.04
- ACTHAR (Biological) $27.96
- BYDUREON (Drug) $25.84
- STIOLTO RESPIMAT (Drug) $25.08
- XARELTO (Drug) $24.31
- EVENITY (Biological) $22.67
- Kerendia (Drug) $19.60
- Rybelsus (Drug) $18.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pahrump
Robert Vance, D.o, D.O
Internal Medicine — Payments: $4,039
Dr. James Flowers, M.d, M.D
Internal Medicine — Payments: $1,935
Dr. Charles Knight, Md, MD
Internal Medicine — Payments: $271.03
Michele Griffith, Md, MD
Internal Medicine — Payments: $104.80